SARS-CoV-2 Na'urorin Gwajin Antigen Saurin

SARS-CoV-2 Na'urorin Gwajin Antigen Mai Sauri,
COVID 19 mai sauri, Gwajin saurin COVID-19, Kit ɗin Gwajin gaggawa, gwajin sauri tabbatacce, sakamakon covid 19, gwada covid 19,
Amfani da Niyya
SARS-CoV-2 Saliva Antigen Rapid Detection Kit (Latex Chromatography) za a yi amfani da shi tare da bayyanar asibiti da sauran sakamakon gwajin dakin gwaje-gwaje don taimakawa wajen gano marasa lafiya da ake zargi da kamuwa da cutar SARS-CoV-2.Gwajin
kwararrun likitoci ne kawai za a yi amfani da su.Yana ba da sakamakon gwaji na farko kawai kuma ya kamata a yi ƙarin takamaiman hanyoyin gano cutar don samun tabbacin kamuwa da cutar SARS-CoV-2.don amfanin sana'a kawai.

Ƙa'idar Gwaji
Ƙididdigar gudana ta gefe ce da ta dace da gano kasancewar furotin nucleocapsid (N) a cikin samfuran numfashi na sama.An ƙirƙira wannan kimar kwarara ta gefe tare da tsarin rigakafin rigakafi na sanwici sau biyu.

Babban Abubuwan Ciki

Abubuwan da aka bayar an jera su a cikin tebur.

Gudun Ayyuka

1. Bude akwati.Yi amo "Kruuua" daga makogwaro don share miyagu daga zurfin makogwaro, sannan tofa miya (kimanin 2 ml) a cikin akwati.Kauce wa kowa
gurbacewar miyagu na waje na gandun.
2. Mafi kyawun lokacin tattara samfuran: Bayan tashi da kuma kafin goge haƙora, ci ko sha.
Bayan mintuna 15, karanta sakamakon a gani.(Lura: KADA ku karanta sakamakon bayan mintuna 20!)

Tafsirin sakamako

Sakamako Mai Kyau
Makada masu launi suna bayyana a duka layin gwaji (T) da layin sarrafawa (C).Yana nuna sakamako mai kyau ga antigens SARS-CoV-2 a cikin samfurin.

Sakamako mara kyau
Ƙungiya masu launi suna bayyana a layin sarrafawa (C) kawai.Yana nuna cewa tattarawar antigens SARS-CoV-2 babu ko ƙasa da iyakar gano gwajin.

Sakamakon mara inganci
Babu bandeji mai launin gani da ke bayyana a layin sarrafawa bayan yin gwajin.The
Wataƙila ba a bi kwatance daidai ba ko gwajin ya lalace.Ana ba da shawarar cewa a sake gwada samfurin.

Bayanin oda

Muna farin cikin sanar da cewa an baiwa #Bioantibody lasisi don yin gwajin saurin gano cutar ta COVID-19.Wannan wani bangare ne na ci gaba da jajircewarmu na samar da amintaccen sabis na kula da lafiya a yayin da ake fama da cutar.